Acne in Skin of Colour: Challenges and Advances in Management

10 min

Speaker

Speaker profile

Hazel Oon

Singapore

Dr. Hazel Oon heads the Psoriasis Unit and Acne Clinic at the National Skin Centre, Singapore. She obtained her medical degree from the University of Toronto. Dr. Oon serves as Medical Advisor to the Psoriasis Association of Singapore, Regional Coordinator for the Global Psoriasis Atlas (GPA), Chair of the Chapter of Dermatologists in Singapore 2023 – 2025, Skin Research Institute of Singapore (SRIS) scientist, and Executive Committee Member of the Skin Research Society of Singapore. She is also the Clinical Educator Lead for undergraduate dermatology in the three medical schools in Singapore, Principal Lead for dermatology at the Lee Kong Chian School of Medicine, and Clinical Lecturer for the Yong Loo Lin School of Medicine. Dr. Oon is the principal investigator in several Phase III biologic trials on psoriasis and hidradenitis and has authored guidelines on psoriasis, acne, and rosacea. Her areas of interest are psoriasis, acne, hidradenitis suppurativa, rosacea, and photo dermatology.

Source event

Event thumbnail

ACNE | Global Education Day 2025

Welcome to the ACNE | Global Education Day 2025!


ACNE | Education Series, organized by Dr. Jerry Tan, is a global medical education initiative aimed at advancing medical awareness and education among dermatology specialists on acne.


📅 Date: June 7, 2025

🕘 Time: 08:00 - 14:00 (Your Local Time Zone)

🌍 Location: Online at www.global-dermatology.com

💰 Registration: Complimentary 🎉

👩‍⚕ Who Should Attend? Dermatologists & Healthcare Providers Treating Acne


Join world-renowned experts as they explore the latest breakthroughs in acne pathophysiology, treatment innovations, and patient-centered care. The esteemed Global Faculty includes:


✔ John Barbieri (USA)

✔ Vincenzo Bettoli (Italy)

✔ Brigitte Dréno (France)

✔ Jonette Keri (USA)

✔ Alison Layton (UK)

✔ Hazel Oon (Singapore)

✔ Apostolos Pappas (Greece)

✔ Joann See (Australia)

✔ Linda Stein Gold (USA)

✔ Maurice Van Steensel (Singapore)

✔ Jerry Tan (Canada)

✔ Howa Yeung (USA)

✔ Christos Zouboulis (Germany)


Why Attend?


✅ Complimentary registration—no cost to attend!

✅ Gain cutting-edge insights from top acne experts

✅ Engage in interactive discussions & live Q&A

✅ Enhance your clinical skills with evidence-based strategies


📢 Secure Your Spot and Register Today!

June 7, 2025Live Event

Description

Dr. Oon examines the distinctive dermatological challenges faced by individuals with darker skin tones, which encompass post-inflammatory hyperpigmentation (PIH) and scarring. Her discourse accentuates Singapore's diverse cultural milieu and investigates tailored therapeutic approaches, highlighting the imperative for culturally informed care. She systematically evaluates progressions in laser therapies, topical agents, and combination modalities, as well as methodologies to mitigate adverse effects. Dr. Oon underscores the critical nature of early intervention and patient education to improve acne management outcomes within communities of color.

Similar videos

Loading...

Source event Program

ACNE | INTRODUCTION

Partner image

Introduction to the Acne Education series

Dr. Tan graduated in medicine from Queen’s University in Kingston, Ontario, Canada and trained in internal medicine at the University of Toronto. He trained in dermatology at University of British Columbia and University of Michigan. He practices in Windsor Ontario Canada. Research focus includes acne, acne scars and rosacea. He has an interest in shared decision making and his group has developed patient decision aids in dermatology – on acne, psoriasis, rosacea and hidradenitis suppurativa – available at [http://www.informed-decisions.org<http://www.informed-decisions.org/>]www.informed-decisions.org<http://www.informed-decisions.org/> He is the past President of the Acne and Rosacea Society of Canada, co-chair of the Acne Core Outcomes Research Network (ACORN), a co-author of acne guidelines for the AAD, Canada, Singapore and the Emirates and has been an associate editor of the JAAD and the BJD. Over the past 3 decades, he has authored/co-authored more than 150 peer-reviewed publications.

ACNE | EPIDEMIOLOGY AND BURDEN

Chair: Prof. Jerry Tan. Panelists: Dr. Jonette Keri, Dr. Howa Yeung

Partner image

Acne in pregnancy and lactation

Jonette Keri, MD PhD is an Associate Professor of Clinical Dermatology at the University of Miami and Chief of the Dermatology Service at the VA Hospital. She is motivated by her patients with acne and has remained involved in various activities to promote the care and study of the condition. Dr. Keri is an author on the most recent Acne Guidelines, published by the American Academy of Dermatology, and an invited member for the recently initiated guidelines. In addition, she is involved in the Acne Core Outcomes Research Network (ACORN), where they strive to identify and clarify outcome measures in acne and is a member of the International Dermatology Outcome Measure group (IDEOM). Being involved in national and international activities that support and expand acne research is an integral part of Dr. Keri’s long-term goal to help as many people as possible with this condition. She understands that the expansion of integrative dermatology is essential for practitioners to access all treatment options associated with the common condition of acne.
Partner image

Burden of acne

Dr. Howa Yeung is a dermatologist in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Children's Healthcare of Atlanta and Emory University Hospital Midtown. He received his medical degree from New York University Grossman School of Medicine and has been in practice between 11-20 years. Dr. Howa Yeung has expertise in treating acne, shingles, psoriasis, among other conditions - see all areas of expertise. Dr. Howa Yeung accepts Medicare, Aetna, Cigna, Blue Cross, United Healthcare - see other insurance plans accepted.
Partner image

Acne cases and conundrums

Linda Stein, MD. Division Head, Dermatology; Associate Director, Dermatopharmacology Research, Henry Ford Hospital, Detroit, Michigan.
Partner image

Q & A - Epidemiology and Burden of Acne

Jonette Keri (MD, PhD)

SPONSORED PRESENTATION | GALDERMA

Partner image

Topical Trifarotene in acne and acne scarring: the START study

Dr. Tan graduated in medicine from Queen’s University in Kingston, Ontario, Canada and trained in internal medicine at the University of Toronto. He trained in dermatology at University of British Columbia and University of Michigan. He practices in Windsor Ontario Canada. Research focus includes acne, acne scars and rosacea. He has an interest in shared decision making and his group has developed patient decision aids in dermatology – on acne, psoriasis, rosacea and hidradenitis suppurativa – available at [http://www.informed-decisions.org<http://www.informed-decisions.org/>]www.informed-decisions.org<http://www.informed-decisions.org/> He is the past President of the Acne and Rosacea Society of Canada, co-chair of the Acne Core Outcomes Research Network (ACORN), a co-author of acne guidelines for the AAD, Canada, Singapore and the Emirates and has been an associate editor of the JAAD and the BJD. Over the past 3 decades, he has authored/co-authored more than 150 peer-reviewed publications.

ACNE | PATHOPHYSIOLOGY

Chair: Prof. Jerry Tan, Panelists: Prof. Maurice van Steensel MD, PhD, Dr. Vincenzo Bettoli MD

Partner image

Updated acne pathogenesis

Professor Maurice van Steensel studied medicine at the Catholic University Nijmegen, Netherlands, obtaining his MD in 1996, and completed a cum laude PhD in genetics and dermatology in 2005 from Maastricht University, Netherlands. Prof van Steensel is an experienced and highly regarded dermatologist with a PhD in molecular genetics. He is a renowned expert in genetic skin disorders and has improved our understanding of many skin diseases. In Singapore, he uses his experience to discover new drugs to treat a range of common skin diseases. He is currently working on acne and oily skin. The results are transforming our insight into these common conditions and his work will soon result in new treatments. Prof van Steensel has a leading role in the new Skin Research Institute of Singapore (SRIS). He wants to conduct science that benefits patients and consumers in Singapore and the rest of the world. As a clinician-scientist, Prof van Steensel believes that doctors should be able to drive advances in medicine. Thus, they must have a solid training in the sciences. He also thinks that doctors must know a lot about skin. Skin diseases, after all, are among the most common conditions in the world and by several measures, skin can be said to be the largest organ in the body. Prof van Steensel is very passionate about Science and skin biology. He inspires and teaches students to become great doctors who care about science (and skin).
Partner image

Acne syndromes including overlap with HS

Dr. Vincenzo Bettoli is an Italian dermatologist and venereologist specializing in acne and related disorders such as hidradenitis suppurativa, rosacea, and folliculitis. He has directed the “Acne and Hidradenitis Suppurativa Clinic” at the University of Ferrara and currently leads research programs and clinical services in Bologna. Dr. Bettoli has authored over 250 scientific publications and two books on acne scars, and has served in leadership roles including President of the Italian Group of Epidemiological Studies in Dermatology (GISED). He is actively involved in international dermatological research and clinical trials.
Partner image

The sebaceous gland and lipids in acne

Professor of Dermatology, Venereology and Allergology at the Brandenburg Medical School Theodor Fontane and the Faculty of Health Sciences Brandenburg and Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Dessau, Germany. He is also Professeur honoraire at the Medical Faculty, University of Franche-Comté, Besançon, France and Dr. h.c. of the National and Kapodistrias University of Athens, Greece.
Partner image
Partner image

Q & A - Pathophysiology of Acne

Vincenzo Bettoli (MD), Christos Zouboulis (MD)

SPONSORED PRESENTATION | CYSPERA

Partner image

Unlocking the Power of Cysteamine Isobionic Complex: A New Frontier in Managing Post-Inflammatory Hyperpigmentation in Acne

Dr. Behrooz Kasraee is a renowned physician dermatologist and researcher whose passion for skin pigmentation concerns has led him to become one of the leaders in this field of study. Not only is he the only person to successfully find a way to stabilize cysteamine, but he also runs one of the most successful vitiligo clinics in the world. He identified a series of new skin depigmenting agents such as methimazole, ebselen and isoniazide. Dr. Kasraee has set forth the concept of H2O2-mediated melanin synthesis and its role as a defence mechanism against oxidative stress. He is at the origin of novel in vitro methods for melanosomal transfer measurement. Behrooz, MD, was instrumental in developing the new pigment corrector formulated with cysteamine. Dr. Kasraee is founder & chairman of Scientis & Swiss Vitiligo Center.

ACNE | MANAGEMENT

Partner image

Systemic therapy in acne (excl isotretinoin)

Dr Jo-Ann See has worked at Central Sydney Dermatology since 1993 and has been a principal here for over 25 years. After obtaining her medical degree with honours from the University of New South Wales in 1985, she completed her residency at the Prince of Wales Hospital and then her Dermatology training at both Prince of Wales and St Vincent’s Hospitals in Sydney. Her post Fellowship training in Psoriasis was completed at Baylor Medical School, Dallas Texas. As a member of the American Academy of Dermatology and the European Academy of Dermatology and Venereology she regularly attends national and international annual scientific meetings to stay up to date. Dr See has served on the State and Federal boards of the Australasian College of Dermatologists as well as having been a guest examiner for the Fellowship examinations. She has been involved in clinical trials, product launches and has introduced innovative treatments to Australia. Her key interests are skin care, sun damage, skin cancer and acne. She is a pioneer in the field treatment of actinic keratosis (pre-cancers) with daylight photodynamic therapy. Dr See is at the forefront of acne treatment in Australia. She is invited as the sole Australian representative to the International Global Alliance to improve Outcomes in Acne. She, together with liked-minded colleagues, spearheaded the formation of a non-profit health initiative, All About Acne, and has been its long standing chair/co-chair since its foundation. Dr See attends and is an invited speaker both nationally and internationally. She has made regular appearances in press, radio and television discussing, clarifying and de-mystifying dermatology issues. She has also consulted with the College of Dermatology as well as industry in providing patient information for the general public and teaching material for general practice.
Partner image

Topical acne therapies

John Barbieri, MD, MBA is an Assistant Professor at Harvard Medical School and the Director of the Advanced Acne Therapeutics Clinic at the Brigham and Women’s Hospital. He is an associate editor at JAMA Dermatology and is also the co-chair of the American Academy of Dermatology Acne Guidelines Work Group. His research is focused on conducting innovative clinical trials, health economic, and epidemiology studies to identify the best approaches to care for patients with acne. He also focuses on exploring the role of patient-reported outcomes to ensure we are capturing the patient’s voice and perspective on their care.
Partner image

Diet and nutrition in acne

Dr. Pappas received his doctorate from Rutgers University in ’99 and began his professional career as a researcher in the Skin Research Center of Johnson & Johnson. Later, in 2001, he served as a group leader at Munich Biotech, where he worked on cancer research. In 2003, he returned to J&J, where he was a Research Manager and Fellow focusing on skin lipid research. Dr. Pappas is one of the first to culture cells that were previously not cultured; as human primary sebocytes and human facial preadipocytes. He has authored 40 peer-reviewed scientific publications, patents, and four books. While at J&J, he collaborated with many experts and KOLs to open a new field within the academic textbook arena and curriculums on “Nutrition and Skin”, published by Springer in 2011. The success and wide recognition of this project paved the way for his second textbook by Springer in 2014: “Lipids and Skin Health”; also the very first of its kind. Dr. Pappas joined as an adjunct faculty the Dept. of Food Science at Rutgers University (since 2013) and the Rutgers Center for Lipid Research. He was also appointed on the scientific advisory board of directors of the CARF Society and as a Trustee in the Board of TRI Princeton (a hair research Institute). In 2018 he moved to Switzerland to Head the Nestle Skin Health’s Innovation Center as the Head of all Programs for Dermatology, Aesthetics and Cosmetics. The summer of 2020 Dr. Pappas founded Apomach LLC in Switzerland a startup company focusing on tissue regeneration using a novel injectable technology for age induced Facial Fat loss. In the meantime he is the Senior Dermatology Consultant for PPM Nogra Pharma in Switzerland and the Senior Dermatology Consultant for Entrinsic Biosciences in Norwood, MA where he builds a new skincare and biology research department. His interdisciplinary training and experience in lipids, metabolism, stem cells, microbiome and skin research has led him to initiate and chair major symposia and lectures in many prestigious societies and universities
Partner image

Oral isotretinoin in acne

Professor Alison Layton, M.B;Ch.B.; FRCP was appointed as Consultant Dermatologist at Harrogate and District NHS Foundation Trust in 1994 and Honorary Professor at Hull York Medical School in 2012. She has a particular interest in androgen mediated disorders including acne and polycystic ovary syndrome (PCOS). She sits on the Executive Council of PCOS UK. She has acted at Chief Investigator and Principal investigator for many clinical trials embracing acne and rosacea as well as other inflammatory dermatoses.
Partner image

Microbiome in Acne: what is actionable in clinical practice?

National Academy of Medicine Division: Medicine and medical specialties (France) Total publications (since 1977): 918 h factor: 66. SCI (Without self citations): 31566. SIGAPS score: 8954 UNIVERSITY TITLES 2016 President of the CNU – Dermatology – 50th section – 3rd subsection (Nantes, France) 2013 Elected member of the National Council of Universities – Dermatology – 50 th section – 3 rd sub-section 2011 University Professor Exceptional class 2nd level HOSPITAL TITLES AND FUNCTIONS Since 2014 Head of Department of Dermato-Cancerology Since 1993 Founder and Director of the Cellular and Gene Therapy Unit (UTCG) of the University Hospital of Nantes HONORABLE DISTINCTIONS 2015 Appointment to the rank of Knight in the Order of Academic Palms 2013 2013 International League of Dermatological Societies (ILDS) Award 2005 Prize for Victories in medicine, specialty “Cancerology” ACADEMIC RESPONSIBILITIES Since 2020 Deputy Vice-President for Scientific and Technical Culture at the University of Nantes Since 2012 Director of group 2 “Translational and clinical research on melanoma” within the Cancer Research Center (CRCINA U1232) in Nantes 2011 – 2020 Vice-Dean for Research of the Faculty of Medicine of Nantes Since 2005 Founder and Coordinator of the Biotherapy Module of the Clinical Investigation Center of Biotherapy INSERM CBT0503 OTHER DUTIES AND RESPONSIBILITIES 2021 Sponsor of the association ELLES à la Santé 2018 Elected president of the committee in charge of the scientific program of the annual congress of the Academy: European Academy of Dermatology and Venereology (European Academy of Dermatology and Venereology) (EADV) 2015 Elected Board Member and Treasurer of the International League of Dermatological Societies (ILDS) which coordinates Dermatology societies on a global level and ensures relations with the WHO for skin conditions ACADEMIC SOCIETIES 2019 Founding Member and Member of the Board of Directors of the French Society of Cancer Immunotherapy (FITC) 2016 Chair of the scientific committee in charge of the scientific program of the EADV 2014 Founding Member of the “Melanoma Word Society” (MWS) 2015 Treasurer of the ILDS 2014 Member of the scientific committee of the European Society of Dermatology (EADV) 2010 -2012 President of the College of Teachers of Dermatology of France (CEDEF) 2004 – 2006 President of the French Society of Dermatology (SFD). Vice-President of the French Society of Dermatology: 2003 Member of the Board of Directors: 2002 2002 – 2005 Founding member of the French Society of Cellular and Gene Therapy 2009 Board member of the “Skin Cancer Foundation” 2005 Foreign member of the Canadian Society of Dermatology 1994 Full member of the “International Society for Cutaneous Lymphomas” (ISCL). Member of the Office from 2000 to 2010 1990 Full Member of the American Academy of Dermatology (AAD) 1987 Full Member of the “European Society for Dermatological Research” (ESDR) 1982 Founding member of the French Society for Research in Dermatology (SRD). Board member: 1989 to 1992 CONGRESS ORGANIZATION European Congresses: 2011 Organizer and Session Chair of the 7th European Association of Dermatology Oncology – Nantes – (EADO)
Partner image

Acne in Skin of Colour: Challenges and Advances in Management

Dr. Hazel Oon heads the Psoriasis Unit and Acne Clinic at the National Skin Centre, Singapore. She obtained her medical degree from the University of Toronto. Dr. Oon serves as Medical Advisor to the Psoriasis Association of Singapore, Regional Coordinator for the Global Psoriasis Atlas (GPA), Chair of the Chapter of Dermatologists in Singapore 2023 – 2025, Skin Research Institute of Singapore (SRIS) scientist, and Executive Committee Member of the Skin Research Society of Singapore. She is also the Clinical Educator Lead for undergraduate dermatology in the three medical schools in Singapore, Principal Lead for dermatology at the Lee Kong Chian School of Medicine, and Clinical Lecturer for the Yong Loo Lin School of Medicine. Dr. Oon is the principal investigator in several Phase III biologic trials on psoriasis and hidradenitis and has authored guidelines on psoriasis, acne, and rosacea. Her areas of interest are psoriasis, acne, hidradenitis suppurativa, rosacea, and photo dermatology.
Partner image
Partner image
Partner image
Partner image
Partner image

Q & A - Management of Acne

JoAnn See (MD), John Barbieri (MD MBA, FAAD), Alison Layton (M.B, Ch.B., FRCP), Brigitte Dreno (MD, PhD), Hazel Oon (MD, MRCP, MMed Internal Medicine)

SPONSORED PRESENTATION | EUCERIN

Partner image

Acne leaves its marks - Clinical Insights on Thiamidol, Salicylic Acid and Licochalcone A

Professor Firas Al-Niaimi is a highly respected consultant dermatologist with over 20 years of medical experience. He trained at some of the UK’s top hospitals, including the renowned St John’s Institute of Dermatology at St Thomas’ Hospital, where he completed a prestigious laser and Mohs surgical fellowship. He continued as an honorary consultant and pursued further advanced laser training in several U.S. centers. An internationally recognized and multi award-winning expert, Professor Al-Niaimi has authored over 230 scientific publications, contributed 10 book chapters, and published his own book. He has delivered more than 500 scientific lectures across 58 countries and trained over 1,000 doctors worldwide in advanced laser techniques. Alongside his thriving private practice in London’s most exclusive areas, he remains actively involved in academic research, teaching, and international training. His dedication and innovation in dermatology earned him the Global Excellence Award for Consultant Dermatologist of the Year in both 2019 and 2022. In 2021, he was appointed Professor of Dermatology, becoming the UK’s first and only Professor of Laser Dermatology—a testament to his leadership and global impact in the field. Today, he continues to be a leading voice in laser dermatology worldwide.

CONCLUSION

Partner image

Conclusion - Acne Education series

Dr. Tan graduated in medicine from Queen’s University in Kingston, Ontario, Canada and trained in internal medicine at the University of Toronto. He trained in dermatology at University of British Columbia and University of Michigan. He practices in Windsor Ontario Canada. Research focus includes acne, acne scars and rosacea. He has an interest in shared decision making and his group has developed patient decision aids in dermatology – on acne, psoriasis, rosacea and hidradenitis suppurativa – available at [http://www.informed-decisions.org<http://www.informed-decisions.org/>]www.informed-decisions.org<http://www.informed-decisions.org/> He is the past President of the Acne and Rosacea Society of Canada, co-chair of the Acne Core Outcomes Research Network (ACORN), a co-author of acne guidelines for the AAD, Canada, Singapore and the Emirates and has been an associate editor of the JAAD and the BJD. Over the past 3 decades, he has authored/co-authored more than 150 peer-reviewed publications.

Might interest you

Cutaneous Medicine: Multidisciplinary Approaches in Dermatology
PsychodermatologyDermoscopyNeglected Tropical Disease

Cutaneous Medicine: Multidisciplinary Approaches in Dermatology

Chair: Prof. Fahafahantsoa Rapelanoro Rabenja,

This course explores the intersection of dermatology with other medical specialties, emphasizing a collaborative approach to diagnosing and managing complex skin disorders. It covers a wide range of topics, including dermatopathology, rheumatology, oncology, and infectious diseases, highlighting how systemic conditions manifest cutaneously. With contributions from experts in various fields, the text provides comprehensive insights into multidisciplinary care, advanced diagnostic techniques, and innovative treatments. Ideal for dermatologists, internists, and specialists, it bridges gaps between disciplines to improve patient outcomes in cutaneous medicine.

Pigmentation
Pigmentation

Pigmentation

Chair: Dr Seemal Desai, MD, FAAD

Hyperpigmentation is excess skin color from melanin. Understand melanin synthesis mechanisms and main causes.

Neglected Tropical Skin Diseases
Neglected Tropical Disease

Neglected Tropical Skin Diseases

Chair: Dr. Prajwal Pudasaini, MD

Neglected tropical skin diseases affect poor populations in tropical areas. They include leprosy, mycetoma, and cutaneous leishmaniasis, causing disability and stigma. They receive little attention and resources, leading to poor diagnosis and treatment. Increased awareness and improved healthcare access are needed to help affected communities.

Acne Treatment in China
TCM Chinese Medicine

Acne Treatment in China

Chair: Prof. Haiping Zhang, PhD

Acne treatment in China combines traditional methods with modern practices.

Cyspera Medical Education
Pigmentation

Cyspera Medical Education

Chair: Global Dermatology,

Cyspera® is a topical pigment-correcting treatment formulated with cysteamine, a naturally occurring compound that reduces the appearance of persistent hyperpigmentation, including melasma, post-inflammatory hyperpigmentation, and lentigines. It is known for being non-hydroquinone, suitable for long-term use, and effective on all skin types.

Topographic Dermoscopy

Topographic Dermoscopy

Chair: Prof. Awatef Kelati, MD

Topographic dermoscopy refers to the region-specific application of dermoscopic examination, emphasizing the unique morphological patterns found across different anatomical sites. On facial skin, the dermoscopic assessment requires recognizing patterns influenced by the high density of pilosebaceous units and sun-induced changes, often presenting pseudonetworks and annular-granular structures. The ear, with its thin skin and sebaceous gland concentration, reveals specific vascular and follicular clues important in distinguishing benign from malignant lesions.

On the chest and back, where the skin is thicker and sun exposure varies, dermoscopy must account for irregular pigment distribution and architectural disorder, especially in large nevi or early melanomas. Limb lesions may show distinctive features due to mechanical friction, hair density, and vascular variations, demanding precise interpretation to identify atypical nevi or skin cancers.

Palmar and plantar dermoscopy highlights the parallel ridge pattern critical for melanoma diagnosis, contrasting with benign acral patterns like the parallel furrow or lattice-like structures. Scalp and hair disorders benefit from trichoscopy, where dermoscopic evaluation reveals specific signs such as yellow dots, broken hairs, or black dots, aiding in the diagnosis of alopecia areata, androgenetic alopecia, or tinea capitis.

In nail disorders, onychoscopy enables visualization of melanonychia, hemorrhages, and nail matrix changes, crucial for distinguishing subungual melanoma from benign causes like trauma or fungal infection. Mucosal dermoscopy, though technically challenging, provides diagnostic clues in pigmented lesions of the lips, genitalia, or oral mucosa, requiring adaptation to moist, non-keratinized surfaces.

Finally, ultraviolet dermoscopy reveals a unique application: scabies mites fluorescing bright green under UV light, enhancing detection when traditional visualization fails. Topographic dermoscopy thus demands both anatomical knowledge and technical adaptation to maximize diagnostic accuracy across diverse body sites.

ACNE
Acne

ACNE

Chair: Dr. Jerry Tan, MD

The ACNE | Education Series, led by Dr. Jerry Tan, is a comprehensive global medical education initiative designed to enhance the understanding and skills of dermatologists and healthcare practitioners regarding acne. Participants will gain insights from leading international experts on the latest advancements in acne research, innovative treatment options, and patient-centered care approaches. The event features interactive discussions, live Q&A sessions, and evidence-based strategies, all at no cost. The esteemed faculty includes specialists from the USA, Italy, France, the UK, Singapore, Greece, Australia, Canada, and Germany. This is a valuable opportunity to improve clinical competencies and stay updated on current acne management practices.

Attendees will acquire up-to-date knowledge on acne pathophysiology, new therapeutic options, and patient-oriented management strategies to optimize clinical outcomes in acne treatment. The session will also provide practical insights through expert-led discussions and evidence-based approaches.

Psychodermatology
Psychodermatology

Psychodermatology

Chair: Prof Mohammad Jafferany, MD

This specialized course explores the vital intersection between dermatology and mental health, equipping clinicians with the knowledge and tools to manage psychodermatological conditions effectively. Through a blend of theoretical knowledge and practical application, participants will learn to diagnose and treat dermatological delusional disorders, identify psychiatric comorbidities in skin disease patients, and implement mental health strategies for chronic dermatoses. The curriculum also examines psychological factors in cosmetic dermatology and provides cutting-edge screening techniques for body dysmorphic disorder, including modern digital manifestations like Zoom dysmorphia. Adopting a patient-centered approach, the course emphasizes multidisciplinary management of conditions where psychological and dermatological factors interact. Participants will gain expertise in recognizing psychiatric components of skin diseases, addressing the emotional

burden of chronic conditions, and applying ethical principles in cosmetic practice. The training combines expert instruction with case-based learning to bridge theory and clinical practice. Designed for dermatologists, psychiatrists, psychologists, and primary care providers, this program enhances clinicians' ability to deliver holistic care that addresses both the visible and invisible aspects of skin disorders. Upon completion, practitioners will be better prepared to manage complex psychodermatological cases while improving patient outcomes through integrated mind-skin healthcare.


Tropical Dermatology and Neglected Tropical Dermatoses
Neglected Tropical Disease

Tropical Dermatology and Neglected Tropical Dermatoses

Chair: Prof. Fahafahantsoa Rapelanoro Rabenja,

Dermatological diseases, particularly neglected tropical diseases (NTDs) with skin manifestations like deep mycosis (chromoblastomycosis, sporotrichosis, mycetoma), scabies, leprosy, lymphatic filariasis, and cutaneous leishmaniasis, pose major challenges for healthcare systems in resource-limited regions of Africa, Asia, and Latin America. These conditions severely affect vulnerable populations, suffering from frequent underdiagnosis and inadequate treatment that exacerbates suffering. Diseases such as atopic dermatitis are also under consideration for inclusion as skin NTDs through collaborative efforts involving ISAD, ASDV, and WHO. Furthermore, albinism, highly prevalent in sub-Saharan Africa, presents significant social challenges including stigmatization and occult beliefs. Despite these complex difficulties, the field is undergoing a historic transformation driven by science and technology, particularly artificial intelligence (AI), which offers tangible tools for improving diagnosis, treatment, and prevention. The participation of global experts facilitates vital knowledge exchange, exploration of innovative solutions, and helps address critical shortages of human and material resources in remote areas.


Learning Objective:

Understand the complex challenges posed by dermatological diseases, especially skin NTDs and conditions like albinism, in resource-limited settings, and recognize the critical role of global collaboration, technological innovation (particularly AI), and expert knowledge exchange in developing solutions to improve diagnosis, treatment, prevention, and resource allocation.

Dermoscopy
Dermoscopy

Dermoscopy

Chair: Prof Awatef Kelati, MD

This comprehensive dermoscopy course provides dermatologists and healthcare professionals with essential skills in skin lesion evaluation, covering fundamental principles through advanced diagnostic applications across five key areas: global dermoscopy practices, pigmented lesion analysis (including differentiation of benign and malignant patterns), specialized techniques for skin of color, skin cancer detection (melanoma and non-melanoma), and general dermatological conditions (inflammatory, infectious, and hair/nail disorders). Participants will develop proficiency in recognizing diagnostic patterns, adapting techniques for diverse skin types, and applying dermoscopic algorithms, ultimately enhancing their clinical accuracy through a combination of theoretical knowledge and practical case-based learning. The course emphasizes real-world application, addressing both common and challenging scenarios in dermatological practice.